Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Breast Cancer–Related Lymphedema: Personalized Plans of Care to Guide Survivorship

Breast Cancer–Related Lymphedema: Personalized Plans of Care to Guide Survivorship PurposeTo present and discuss care domains (oncologic, cardiometabolic, aging, behavioral, environmental) for clinicians when approaching care for a breast cancer survivor at risk for developing breast cancer–related lymphedema (BCRL), as well as survivors who have been diagnosed with BCRL. Assessment using each domain aids in decision-making, yet also identifies barriers to pursuing personalized care for survivors with BCRL.Recent FindingsBCRL occurs from damage to the lymphatics during breast cancer treatment and occurs in approximately 20 to 40% of survivors. Prospective surveillance and early treatment for BCRL are supported in the literature; however, these approaches are frequently not used within evidence-based recommendations.SummaryThe five domains can be used to develop a personalized plan of BCRL care. Barriers to pursuing personalized care for survivors with BCRL are identified. Future work in developing evidence-based recommendations is needed to guide clinicians and survivors during prospective surveillance, successful risk reduction, early diagnosis, and treatment of BCRL. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Current Breast Cancer Reports Springer Journals

Breast Cancer–Related Lymphedema: Personalized Plans of Care to Guide Survivorship

Loading next page...
 
/lp/springer-journals/breast-cancer-related-lymphedema-personalized-plans-of-care-to-guide-kCvNOjaQYy
Publisher
Springer Journals
Copyright
Copyright © Springer Science+Business Media, LLC, part of Springer Nature 2020
ISSN
1943-4588
eISSN
1943-4596
DOI
10.1007/s12609-020-00380-1
Publisher site
See Article on Publisher Site

Abstract

PurposeTo present and discuss care domains (oncologic, cardiometabolic, aging, behavioral, environmental) for clinicians when approaching care for a breast cancer survivor at risk for developing breast cancer–related lymphedema (BCRL), as well as survivors who have been diagnosed with BCRL. Assessment using each domain aids in decision-making, yet also identifies barriers to pursuing personalized care for survivors with BCRL.Recent FindingsBCRL occurs from damage to the lymphatics during breast cancer treatment and occurs in approximately 20 to 40% of survivors. Prospective surveillance and early treatment for BCRL are supported in the literature; however, these approaches are frequently not used within evidence-based recommendations.SummaryThe five domains can be used to develop a personalized plan of BCRL care. Barriers to pursuing personalized care for survivors with BCRL are identified. Future work in developing evidence-based recommendations is needed to guide clinicians and survivors during prospective surveillance, successful risk reduction, early diagnosis, and treatment of BCRL.

Journal

Current Breast Cancer ReportsSpringer Journals

Published: Sep 4, 2020

There are no references for this article.